Despite established clinical utility, the Acemetacin Market faces several challenges that influence prescribing patterns, regulatory positioning, and market expansion. One of the primary restraints is the class-wide cardiovascular risk associated with NSAID therapy, including increased risk of myocardial infarction, stroke, and thrombotic events that has prompted regulatory warnings and...